We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$14.6B
AUM Growth
+$1.24B
Cap. Flow
+$998M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.27%
Holding
2,202
New
241
Increased
1,177
Reduced
603
Closed
133

Sector Composition

Rank Sector Weight
1 Energy 9.2%
2 Healthcare 8.03%
3 Technology 7.82%
4 Financials 7.64%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
176
McKesson
MCK
$101B
$18.5M 0.13%
104,713
+25,859
+33% +$4.52M
ALL icon
177
Allstate
ALL
$67.5B
$18.5M 0.13%
326,423
+54,977
+20% +$2.95M
BKNG icon
178
Booking.com
BKNG
$161B
$18.4M 0.13%
386,775
-85,925
-18% -$4.24M
TWX
179
DELISTED
Time Warner Inc
TWX
$18.2M 0.12%
290,349
+47,828
+20% +$3M
HAL icon
180
Halliburton
HAL
$26.6B
$18.1M 0.12%
307,283
+50,863
+20% +$2.72M
FCX icon
181
Freeport-McMoran
FCX
$97.5B
$18M 0.12%
545,401
+9,683
+2% +$322K
RGC
182
DELISTED
Regal Entertainment Group
RGC
$17.9M 0.12%
957,348
+86,113
+10% +$1.65M
SBUX icon
183
Starbucks
SBUX
$120B
$17.7M 0.12%
483,706
+114,520
+31% +$4.24M
CB icon
184
Chubb
CB
$135B
$17.7M 0.12%
178,752
+46,174
+35% +$4.48M
LLY icon
185
Eli Lilly
LLY
$1.06T
$17.7M 0.12%
300,361
+13,617
+5% +$760K
ESV
186
DELISTED
Ensco Rowan plc
ESV
$17.6M 0.12%
83,565
+9,976
+14% +$2.09M
UL icon
187
Unilever
UL
$136B
$17.6M 0.12%
365,891
+171,415
+88% +$7.74M
COF icon
188
Capital One
COF
$134B
$17.4M 0.12%
226,002
+26,973
+14% +$1.98M
BDJ icon
189
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$17.4M 0.12%
2,196,084
+340,291
+18% +$2.67M
PII icon
190
Polaris
PII
$4.07B
$17.4M 0.12%
124,368
+14,726
+13% +$1.99M
GIS icon
191
General Mills
GIS
$19.7B
$17.4M 0.12%
335,304
-46,020
-12% -$2.28M
MDLZ icon
192
Mondelez International
MDLZ
$79.9B
$17.3M 0.12%
499,683
-6,502
-1% -$222K
AEP icon
193
American Electric Power
AEP
$68.4B
$17.3M 0.12%
340,591
+3,054
+0.9% +$148K
HYS icon
194
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
$17M 0.12%
159,406
+17,100
+12% +$1.82M
DGX icon
195
Quest Diagnostics
DGX
$26.3B
$17M 0.12%
293,018
+273,915
+1,434% +$14.7M
WY icon
196
Weyerhaeuser
WY
$18.4B
$16.9M 0.12%
575,343
+109,581
+24% +$3.3M
DOC icon
197
Healthpeak Properties
DOC
$14.8B
$16.9M 0.12%
477,522
+221,902
+87% +$7.66M
WBA
198
DELISTED
Walgreens Boots Alliance
WBA
$16.9M 0.12%
255,482
-99,808
-28% -$6.27M
CELG
199
DELISTED
Celgene Corp
CELG
$16.8M 0.12%
241,244
-17,962
-7% -$1.42M
PRE
200
DELISTED
PARTNERRE LTD
PRE
$16.7M 0.11%
161,462
+12,479
+8% +$1.25M

Similar funds

Raymond James & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Raymond James & Associates held 2,202 positions worth $14.6B, up 9.3% from $13.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $998M of net new capital in Q1 2014, opening 241 new positions and adding to 1,177 existing holdings. Its largest new stake was Edgewell Personal Care: 199,912 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 9.2% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vodafone, an estimated $33.9M trimmed.

  • Raymond James & Associates's largest Q1 2014 buy was Edgewell Personal Care: 199,912 shares worth $14.9M.
  • Raymond James & Associates added most to Verizon in Q1 2014, an estimated $31.6M increase.
  • Raymond James & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $33.9M.
  • Raymond James & Associates fully exited Nu Skin in Q1 2014, selling an estimated $5.53M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2014.
  • Raymond James & Associates opened 241 new positions and closed 133 in Q1 2014.
  • Raymond James & Associates's portfolio value rose 9.3% quarter-over-quarter to $14.6B.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.